skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration


Discover the leading Rheumatoid Arthritis (RA) treatments of 2017. At Datamonitor Healthcare, we’ve quadrupled our business, covering more than 90% of prescription medicines in the major markets. We are known for offering the best forecasts, coverage, analysis and support. Which are good enough reasons to download our Rheumatoid Arthritis Sample Pack today.

In it, you will discover:


  • Which inhibitor currently marketed for RA in the US and Japan, is anticipated to launch in the five major EU markets over the forecast period


  • Which inhibitor significantly reduced the radiographic progression of structural joint damage compared to a placebo in the long-term extension study, RA-BEYOND (Lilly, 2016b)


  • The sales of Janus Kinase inhibitors in the US, Japan, and five major EU markets ($m), 2016–25

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: